Immuron (IMRN) Cost of Revenue (2016 - 2024)

Immuron's Cost of Revenue history runs 9 years deep, the most recent figure standing at $874530.9 for Q4 2024.

• In Q4 2024, Cost of Revenue rose 12.81% year-over-year to $874530.9; the TTM figure through Dec 2024 stood at $1.8 million (down 99.64% YoY), while the FY2025 annual figure was $1.6 million, up 59.14% from the prior year.
• Cost of Revenue for Q4 2024 stood at $874530.9, up from $775232.0 in the prior quarter.
• The five-year high for Cost of Revenue was $508.2 million in Q4 2021, with the low at $0.01 in Q4 2020.
• The 5-year median for Cost of Revenue is $465479.0 (2022), against an average of $85.0 million.
• The sharpest annual moves came in 2020 and 2021: Cost of Revenue slumped 100.0% in 2020, then jumped 5630900837882.94% in 2021.
• Immuron's Cost of Revenue stood at $0.01 in 2020, then surged by 5630900837882.94% to $508.2 million in 2021, then tumbled by 99.97% to $155726.0 in 2022, then soared by 397.82% to $775232.0 in 2023, then gained by 12.81% to $874530.9 in 2024.
• Business Quant data shows IMRN's Cost of Revenue at $874530.9 in Q4 2024, $775232.0 in Q4 2023, and $14310.9 in Q2 2023.